Adam Fine

Adam Fine Overview

  • Investor Type
  • Angel
  • Investments
  • 1
  • Portfolio
  • 1

Adam Fine General Information


Mr. Adam Fine is a Co-Founder and serves as Chief Executive Officer, Managing Director and General Partner at Windham Venture Partners. He also serves as Board Member at CredSimple. He is a Board Observer of BehaveCare. He served as Board Member at Coravin. He served as Board Observed at SpineView and CuraSeal. He serves as Director at GlySens and HelpAround, Board Observer to MC10, Holaira and VytronUS. He is a mentor in Blueprint Health, a healthcare IT accelerator in NYC. Prior to Windham, he was Vice President and General Manager at I-many, Inc., an enterprise software company. Prior to joining I-many, he was a New Business Development Analyst at Cordis Corporation, a Johnson & Johnson company focused on interventional vascular devices such as stents. In that capacity, he worked on a range of licenses, acquisitions, divestments, as well as strategic investments with Johnson & Johnson Development Corporation (JJDC), J&J's strategic venture arm. Prior to J&J, he was a research analyst at Coopers & Lybrand's Integrated Healthcare Consulting practice. He received his BA and graduated cum laude with distinction from Boston University and received his MBA from New York University.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 500 Fifth Avenue
  • Suite 3600
  • New York, NY 10019
  • United States
+1 (212) 000-0000

Adam Fine Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000000 16-Jul-2014 00000 00000 00000 Application Software Generating Revenue 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Adam Fine Team (1)

Name Title Deals Funds Boards Office
Adam Fine Angel Investor 00 0 0 New York, NY